Idiopathic NBIA is of unknown origin, although it is suspected to be genetic. For many families, the person diagnosed with NBIA is the first and only affected individual, so it is difficult to know whether there is a specific pattern of inheritance. It is thought that most of these cases are probably recessive because some families have more than one affected child and idiopathic NBIA is more common in families in which the parents are related, such as distant cousins. That would make it more likely that they share a recessive gene.
The symptoms are more varied because there are probably several different causes of neurodegeneration for individuals in this group. As with other forms of NBIA, the idiopathic form features early- and late-onset types. About 35 percent of those diagnosed with NBIA are believed to be in this group.
Click on any of the thumbnail images below to view the photos in a larger size; move cursor to upper right of picture to click on next and view as slideshow:
Suspicion of NBIA usually arises when an MRI of the brain shows excessive iron accumulation, along with a movement disorder. Depending on symptoms, genetic testing is done to rule out other forms of NBIA. If all are negative, but the findings are characteristic of NBIA, then the diagnosis of Idiopathic NBIA is given until further evidence of the genetic origin or another cause is determined.
Doctors treat patients with medication when appropriate. Also, affected individuals may need a feeding tube or other assistance to achieve adequate nutrition. Other therapies might also be warranted.
Testing to find the gene responsible for an individual’s form of NBIA may be pursued.
In the absence of a known genetic mutation, testing during pregnancy to assess risk is not possible.
Researchers continue their search for remaining genes that cause NBIA disorders, and much progress is being made with new technology. Affected individuals diagnosed with Idiopathic NBIA might want to participate in the International Patient Registry. If a new gene is found by researchers, the person’s samples will be examined to see if they have mutations and their form of NBIA identified.